Thomas Lingelbach und Ceo - Info zur Person

(1 - 38 von 73

)

Valneva to Conduct Investor and Partnering Meetings during

www.globenewswire.com

... December 5, – Valneva SE (“Valneva”), announced today that its management team including Thomas Lingelbach, CEO, David...

Intercell gibt eine Finanzierung von EUR 25,0 Mio. durch BB Biotech...

www.pressebox.de

Intercells CEO Thomas Lingelbach, erklärt: "Nach der erfolgreichen strategischen Neupositionierung im Jahr 2011, stellt diese Finanzierung ...

derstandard.at: Thomas Lingelbach wird neuer CEO bei Intercell - Finanzen & Börse -...

Zettlmeissl zieht sich zurück

VALNEVA to Present at the 17th World Vaccine Congress in Washington...

www.informazione.it

Valneva's CEO, Thomas Lingelbach, will focus on the development of a novel ... Thomas Lingelbach, President and CEO and Franck Grimaud, Deputy CEO of ... Facebook Twitter GooglePlus Pinterest Linkedin Tumblr.

Facebook: Valneva - Read an interview with our CEO Thomas Lingelbach...

LinkedIn: Thomas Lingelbach - President & CEO - Valneva | LinkedIn

Sehen Sie sich das Profil von Thomas Lingelbach auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. 8 Jobs sind im Profil von Thomas Lingelbach ...

LinkedIn: Thomas Lingelbach - President & CEO - Valneva | 领英 - LinkedIn

上领英，在全球领先职业社交平台查看Thomas Lingelbach的职业档案。Thomas的职业档案列出了7 个职位。查看Thomas的完整档案，结识职场人脉和查看相似公司 ...

Valneva CEO Interview - Group Strategy (video) | Markets Insider

markets.businessinsider.com

PARIS, January 29, PRNewswire/ --Valneva is a leading European biotech company specialized in innovative vaccines. Thomas Lingelbach, Presid...

Valneva SE (INRLF) CEO Thomas Lingelbach on Q Results -...

seekingalpha.com

· Thomas Lingelbach - Chairman, President and Chief Executive Officer. David Lawrence - Acting Chief Financial Officer.

Valneva CEO Interview - Group Strategy (video)

www.prnewswire.com

Valneva is a leading European biotech company specialized in innovative vaccines. Thomas Lingelbach, President & CEO of Valneva, ...

Valneva's (INRLF) CEO Thomas Lingelbach on Q Results - Earnings...

seekingalpha.com

Valneva SE (OTC:INRLF) Q Results Earnings Conference Call March 21, :00 AM ET Executives Thomas Lingelbach - CEO ...

Quality Day 2021: Entwicklung, Herstellung und Zulassung von ...www.wko.at › branchen › industrie › quality-day-2021

www.wko.at

CEO Thomas Lingelbach, von der VALNEVA AUSTRIA GMBH , ein Forschungs- und Entwicklungsstandort für Impfstoffe, präsentierte uns den Stand bei der ...

Our Team - Valnevavalneva.com › about-us › our-team

valneva.com

Thomas Lingelbach President & Chief Executive Officer. Previous CEO of Intercell, Managing Director for Novartis Vaccines & Diagnostics Germany, ...

Valneva gibt die Auslieferung seines inaktivierten COVID

www.presseportal.de

· Thomas Lingelbach, CEO von Valneva: "Wir freuen uns sehr, unseren inaktivierten Ganzvirusimpfstoff gegen COVID-19 nun in Deutschland ausliefern zu dürfen und damit einen Beitrag zu einem ...

Thomas Lingelbach - Wiki | Golden

golden.com

Thomas Lingelbach. Save to List. Research Request. ENT. Share. CEO of Valneva SE. Overview · Suggestions · Issues · Contributors · Activity. Contents.

Valneva - Group strategy - Thomas Lingelbach - EuroBusiness Media

www.eurobusinessmedia.com

Valneva is a European biotech company specialized in the development, manufacture and commercialization of innovative vaccines. Thomas Lingelbach, CEO of...

Valneva-CEO: Antikörper-Antwort deutlich höher als bei AstraZeneca |...

www.puls24.at

· PULS 24 Anchor Daniel Retschitzegger spricht mit Thomas Lingelbach, dem CEO und ...Gepostet:

Wikipedia: Valneva SE - Wikipedia

Thomas Lingelbach (CEO), Frédéric Grimaud (Chairman of the supervisory board). Products, Development of vaccines. Website, www.valneva.com. Valneva SE is a biotech company developing and commercializing vaccines for infectious ...

Valneva CEO Interview - Half Year Earnings (video) | EPICOS

www.epicos.com

Thomas Lingelbach, President & CEO of Valneva, comments on the results and the Group's evolution. Watch video interview and read transcript: https: //www ...

Interview with Thomas Lingelbach, CEO, Intercell | PharmaBoardroom

pharmaboardroom.com

Can you give a brief summary of how Intercell started, how it developed and where it stands today? Intercell was created in as a spinoff from Vienna

Valneva: "Valneva zündet Turbo - CEO Thomas Lingelbach im Interview"...

analyst-award.at

Valneva, alle Postings, Community, Board,Usermeinung,Lesermeinung

Thomas Lingelbach - President & CEO - Valneva | LinkedIn

www.linkedin.com

View Thomas Lingelbach's profile on LinkedIn, the world's largest professional community. Thomas has 7 jobs listed on their profile. See the complete profile on ...

Edited Transcript of VLA.PA earnings conference call or presentation

finance.yahoo.com

Thomas Lingelbach, Valneva SE - Chairman of the Management Board, CEO & President [1].

Personensuche Thomas Lingelbach Valneva ,CEO auf photaq ...

boerse-social.com

Personensuche Thomas Lingelbach (Valneva, CEO) Treffer st Austria weekly - Valneva; Lenzing, Frequentis ( ) ... vaccine ...

VALNEVA SE (VLA.PA) Company Profile & Facts - Yahoo Financefinance.yahoo.com › quote › VLA.PA › profile

finance.yahoo.com

Mr. Thomas Lingelbach, Chairman of the Management Board, Pres & CEO, k, N/A, Mr. Franck Grimaud MBA, Pres, Chief Bus.

Mr Thomas Lingelbach | Emerging Disease Vaccines - Terrapinnwww.terrapinn.com › conference › speaker-thomas-...

www.terrapinn.com

Following the Intercell-Vivalis merger, Thomas Lingelbach was appointed President & CEO of Valneva. He has been with Intercell since 2006, serving as COO ...

Why Valneva SE's (EPA:VLA) CEO Pay Matters To You

finance.yahoo.com

Thomas Lingelbach became the CEO of Valneva SE (EPA:VLA) in This analysis aims first to contrast CEO compensation with other ...

Thomas Lingelbach - President & Chief Executive Officer at Valnevatheorg.com › org › valneva-se › org-chart › thomas...

theorg.com

Thomas Lingelbach. President & Chief Executive Officer. Join to edit. Previous CEO of Intercell, Managing Director for Novartis Vaccines & Diagnostics ...

Valneva SE (INRLF) CEO Thomas Lingelbach on Q Results -...

flipboard.com

Valneva SE (OTC:INRLF) Q Earnings Conference Call August 1, :00 AM ET Good afternoon, ladies and gentlemen, and thank ...

Lingelbach New CEO for Intercell - Vindobona.org | Vienna...

www.vindobona.org

Intercell announces new management structure: Thomas Lingelbach appointed new CEO; new Supervisory Board members proposed.

VALNEVA to Present on Lyme and Zika at the 18th World Vaccine...

www.trivano.com

Valneva's CEO, Thomas Lingelbach, will provide an update, post Phase 1 interim results , on the development of VLA15, its vaccine candidate against Lyme disease. Lyme ...

Empowered Patient Podcast: Developing Preventative Vaccines for...

empoweredpatientradio.com

Thomas Lingelbach, CEO, Valneva talks about their work developing and commercializing vaccines for infectious diseases with unmet needs. This biotech...

How Valneva are changing the approach to vaccine clinical trials |...

www.pharma-iq.com

Thomas Lingelbach, CEO of Valneva, shares how they set up their trials for success and the innovative methods that could significantly reduce trial timelines

Grünes Licht für EU-Vertrag mit Impfstoff-Hersteller Valneva |...

www.tt.com

· Valneva-CEO Thomas Lingelbach dankte in einer Aussendung der EU für ihre Unterstützung. „Wir erhalten weiterhin Nachrichten von Menschen aus ...

Archive | Chemiereport

www.chemiereport.at

Gegriffen hat das von CEO Thomas Lingelbach eingeleitete Kostenreduktionsprogramm, das die F&E-Ausgaben um 60 Prozent, die Verwaltungs- und ...

Small biotech says its Covid-19 vaccine spurs more antibodies than...

endpts.com

· Valneva CEO Thomas Lingelbach added that his team will now be pursuing licensure for this “alternative vaccine solution for people who have ...

Intercell fusioniert mit Vivalis | Chemiereport

www.chemiereport.at

Der geplante Cross-Border-Merger sei „technisch nicht einfach“, wie Intercell- CEO Thomas Lingelbach, der auch dem neu entstehenden ...

VALNEVA Evaluating Development of Zika Vaccine as Virus Spreads...

www.gate2biotech.cz

Thomas Lingelbach, President and CEO, and Franck Grimaud, Deputy CEO of Valneva commented, "Considering the alarming spread of the ...

Alle Infos zum Namen "Thomas Lingelbach"

Verwandte Suchanfragen zu Thomas Lingelbach

Eckhardt Lingelbach
Sascha Di Carlo

Person "Lingelbach" (2)
Vorname "Thomas" (124868)
Name "Lingelbach" (196)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Thomas Lingelbach und Ceo Person-Info